Literature DB >> 21946854

Comparison of seven infant continuous positive airway pressure systems using simulated neonatal breathing.

Thomas Drevhammar1, Kjell Nilsson, Henrik Zetterström, Baldvin Jonsson.   

Abstract

OBJECTIVE: Continuous positive airway pressure is an established treatment for respiratory distress in neonates. Continuous positive airway pressure has been applied to infants using an array of devices. The aim of this experimental study was to investigate the characteristics of seven continuous positive airway pressure systems using simulated breath profiles from newborns.
DESIGN: Experimental in vitro study.
SETTING: Research laboratory in Sweden. INTERVENTION: None.
MEASUREMENTS AND MAIN RESULTS: In vitro simulation of spontaneous neonatal breathing was achieved with a mechanical lung model. Simulation included two breath profiles, three levels of continuous positive airway pressure with and without short binasal prongs and different levels of constant leak. Pressure stability and imposed work of breathing were determined. Seven continuous positive airway pressure systems were tested. There were large differences in pressure stability and imposed work of breathing between tested continuous positive airway pressure systems. Neopuff and Medijet had the highest pressure instability and imposed work of breathing. Benveniste, Hamilton Universal (Arabella), and Bubble continuous positive airway pressure showed intermediate results. AirLife and Infant Flow had the lowest pressure instability and imposed work of breathing. AirLife and Infant Flow showed the least decrease in delivered pressure when challenged with constant leak.
CONCLUSION: The seven tested continuous positive airway pressure systems showed large variations in pressure stability and imposed work of breathing. They also showed large differences in how well they maintain continuous positive airway pressure when exposed to leak. For most systems, imposed work of breathing increased with increasing continuous positive airway pressure level. The clinical importance of the difference in pressure stability is uncertain. Our results may facilitate the design of clinical studies examining the effect of pressure stability on outcome.

Entities:  

Mesh:

Year:  2012        PMID: 21946854     DOI: 10.1097/PCC.0b013e31822f1b79

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  5 in total

1.  The Effect of a Higher Bias Gas Flow on Imposed T-Piece Resistance and Breathing in Preterm Infants at Birth.

Authors:  Kristel L A M Kuypers; Lieve A Willemsen; Sophie J E Cramer; Aidan J Kashyap; Thomas Drevhammar; Stuart B Hooper; Arjan B Te Pas
Journal:  Front Pediatr       Date:  2022-03-17       Impact factor: 3.418

2.  Imposed Work of Breathing for Flow Meters with In-Line versus Flow-Through Technique during Simulated Neonatal Breathing.

Authors:  Snorri Donaldsson; Markus Falk; Baldvin Jonsson; Thomas Drevhammar
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

3.  In vitro comparison of performance including imposed work of breathing of CPAP systems used in low-resource settings.

Authors:  Megan Heenan; Jose D Rojas; Z Maria Oden; Rebecca Richards-Kortum
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

4.  Comparison of Respiratory Support After Delivery in Infants Born Before 28 Weeks' Gestational Age: The CORSAD Randomized Clinical Trial.

Authors:  Snorri Donaldsson; Thomas Drevhammar; Yinghua Li; Marco Bartocci; Siren Irene Rettedal; Fredrik Lundberg; Per Odelberg-Johnson; Tomasz Szczapa; Thordur Thordarson; Ingrida Pilypiene; Thordur Thorkelsson; Lars Soderstrom; Vladimiras Chijenas; Baldvin Jonsson
Journal:  JAMA Pediatr       Date:  2021-09-01       Impact factor: 26.796

5.  Infant CPAP for low-income countries: An experimental comparison of standard bubble CPAP and the Pumani system.

Authors:  Markus Falk; Snorri Donaldsson; Thomas Drevhammar
Journal:  PLoS One       Date:  2018-05-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.